The current understanding of the pathogenesis RF is that RF is the result of a delayed immune response to Group A B-haemolytic streptococcus (GABHS) pharyngitis after a latent period ranging from 1-5 weeks.
INTRODUCTION
One of the earliest cases, if not the fi rst case, of rheumatic fever (RF) with rheumatic heart disease (RHD) reported in Africa was reported by medical offi cers Procter and Hargreaves in 1932 in the East African Medical Journal.
(1) One of the medical offi cers had been engaged in native practice (1) for eleven years while the other had examined a large number of African school children and neither had found a case of RF or RHD prior. The reported case was that of a 25 year old male from Lumbwa, Kenya admitted to a local hospital with two months duration of painful and swollen joints and a fever. On physical examination, both a systolic and a diastolic murmur were heard consistent with leftsided valvular regurgitation. Infective endocarditis was ruled out since the patient's condition improved with bed rest and salicylates. He was dismissed after about a week of admission and was advised to seek follow up upon discharge. (1) In the 76 years since that case report, RF and RHD have become a major but under-appreciated public health problem in Africa where they account for signifi cant cardiac morbidity and mortality in a substantial number of children and young adults. 
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Intriguing data from Australian aborigines affected by high incidence of RF suggests GABHS pyoderma or even non-GABHS may be responsible for RF and RHD in that population. (16) However, similar data from other high incidence populations does not exist. (17) SEQUELAE OF RHEUMATIC FEVER AND
RHEUMATIC HEART DISEASE
Rheumatic fever affects multiple organs, and the clinical presentation is variable depending on multiple factors including the organs affected, severity of involvement and the time of presentation. (18) The diagnosis of RF is based on the 2002-2003 World Health
Organisation (WHO) revised Jones criteria. (2, 19) Cardiac involvement in RF may be pancarditis, and it is cardiac involvement in the form of valvulitis that is the most important cause of morbidity and mortality. (20) There is evidence of cardiac involvement during the acute episode in 40 to 80% of cases of acute RF21, (21) (22) (23) but cardiac involvement almost always occurs in recurrent episodes of RF. (24) A large majority of those who have carditis during RF episodes will develop progressive RHD from infl ammation and scarring of the heart valves, typically left-sided, which may result in signifi cant valvular regurgitation and or stenosis and heart failure in childhood or early adulthood. (25) Determinants of the outcome of RHD are the age of fi rst attack of RF and the frequency and severity of recurrent attacks. (26) Cardiac involvement in the attack of RF may range from mild to severe and should be suspected on clinical grounds when a murmur (systolic or diastolic) is heard on physical examination or if there is presence of cardiomegaly or unexplained heart failure. (18) Hospital-based studies and cause of death studies across Africa are all consistent and show that RHD is the main cause of cardiac morbidity and mortality in children and young adults, (4) with heart failure being the predominant cause of morbidity and mortality, followed by other complications such as native valve infective endocarditis, systemic embolisation, pulmonary hypertension, atrial arrhythmias, or complications related to valve surgery. (26) (27) (28) (29) (30) (31) (32) The leading cause of heart failure in the forms of RHD typically seen in Africa affecting young individuals in their fi rst or second decades is valve regurgitation mainly of the mitral and aortic valves. (26, 28) It is common clinical course for RF and RHD to result in death in these young individuals (28) and the reasons for this malignant course are not entirely clear, but may partly be related to recurrent episodes of RF with inadequate secondary prophylaxis and multivalvular involvement. (28) Delayed clinical presentation also contributes to high morbidity and mortality. (32) The mechanism of mitral valve regurgitation is related to infl ammation of the mitral valve apparatus leading to dilatation of the mitral anulus and elongation of the chordae and leafl ets which results in prolapse of the anterior mitral leafl et. (26, 33) Aortic valve regurgitation, and less commonly tricuspid valve and pulmonary valve regurgitation are also related to infl ammation of the valve leafl ets and anuli. (34) The presence of mixed valve regurgitation and stenosis or pure valve stenosis is more common in older individuals with chronic and less active rheumatic carditis. (26, 34) Infective endocarditis is a devastating sequelae of RHD where RHD accounts for up to 76.6% of the underlying predisposing condition in some studies. (35) Again, those affected by infective endocarditis are typically young where morbidity and mortality are high due largely to new or worsening heart failure or neurologic complications. (27, 35, 36) In the 3-year prospective epidemiology study of infective endocarditis, Koegelenberg and colleagues found a six month mortality of 35.6%. (35) Rheumatic valve diseases, namely mitral valve stenosis with or without regurgitation, is the most common underlying cardiac condition complicating pregnancies in young women in Africa (37, 38) with a maternal mortality rate of up to 9.5%. (39) It is not unusual for the diagnosis of RHD to be made for the fi rst time late during pregnancy (40) and the attendant consequences of late diagnosis are serious for both mother and child (40, 41) Nqayana and colleagues recently published a retrospective review of all patients admitted with cardiac disease in pregnancy over a 1-year period at their tertiary hospital. 
INCIDENCE AND PREVALENCE OF RF AND RHD

IN AFRICA
The number of new cases of RF per 100 000 per year in Tunisia was 30 in 1990 and in Algeria 11, 1 in 1997 and 6.2 in 2000. (43, 44) There are no reliable data on the number of new cases of RF per year in sub-Saharan Africa (45) and the estimated 13 per 100 000 per year is based on incidence rates from the Middle East and North Africa. (43) Identifying new cases of RF demands active surveillance systems which requires enough skilled manpower and other resources such as laboratories which do not exist in many parts of Africa. (2) The World Health Organisation (WHO) has however demonstrated previously that setting up such surveillance systems is feasible in Africa, but that such systems falter operationally over time. (46) The WHO estimated that there were 12 million people worldwide in 1994 with RF and RHD, the majority of them in developing countries. 
The fi ndings of the study were striking with respect to both the overall prevalence of RHD found in the children as well as the (7) The argument against the standard use of echocardiography to detect valve diseases in Africa centers around cost, lack of equipment and echocardiographic expertise, and potential over diagnosis of valve disease when physiologic regurgitation is found. (2) However, the counter argument for the use of echocardiographic screening and diagnosing of RHD in high prevalent settings is being correctly advanced by some. (2, 17, 53, 54) Echocardiography is superior to physical examination in diagnosing valve disease and it makes sense to try to fi nd models and establish guidelines for proper application of echocardiography for the sake of determining true incidence and prevalence of disease and to identify cases needing secondary prophylaxis. (7, 17) PREVENTION AND MANAGEMENT OF
VALVE DISEASES
The prevention and control of RF and RHD in Africa is now The road to achieving the goal of eradicating RF and RHD has obvious barriers. (56) There is widespread lack of awareness about the causes, symptoms, risks and other problems associated with RF and RHD. (56) Part of this may be related to coexistent high rates of other public health problems such as HIV/AIDS, malaria, and tuberculosis which shift attention away from RF and RHD (17, 56) However, even those affected by RF and RHD often do not receive adequate education or do not understand much of what they are told about the illness. (57) Setting up surveillance systems to capture new cases and regularly follow identifi ed cases requires concerted coordinated effort by an aware, dedicated and well supported health care system with laboratory capabilities.
Advocacy for RF and RHD faded largely due to the virtual disappearance of these diseases in developed nations and the lack of reliable epidemiologic data in Africa and other developing countries that highlight RF and RHD as major public health problems. (17, 56) Primary prevention requires timely treatment of suspected or confi rmed GABHS to prevent RF, but laboratory confi rmation of GABHS remains the gold standard and these laboratory capabilities are not readily available. (2) Rapid diagnostic kits are helpful, but cannot substitute for a laboratory and a negative kit result requires laboratory confi rmation. (58) It is recommended that in communities where RF is endemic, all cases of sore throat in children 3-15 years old be treated as GABHS pharyngitis unless there is ulceration, or hoarseness, or watery nasal congestion, and/or conjunctivitis which argue against GABHS pharyngitis. (59) The WHO Acute
Respiratory Infection Guideline lacks sensitivity for the diagnosis of GABHS pharyngitis since it requires both pharyngeal exudate and tender, enlarged lymph nodes to make the diagnosis. (60) Complicating primary prevention strategies is the absence of symptoms of pharyngitis in a signifi cant proportion of those who develop RF. (61) Secondary prevention is the long-term administration of penicillin after the fi rst episode of RF to prevent recurrence and duration of treatment is tailored to the presence and severity of valve disease according to the WHO recommendations. (2, 59) Secondary prevention is the strategy so far proven most cost effective in the control of RF and RHD and is the main strategy supported by the WHO. (2) This strategy requires identifi cation of cases and establishment of registries of patients to ensure continued coordinated administration of antibiotics every 3-4 weeks. (2) However, whether administration of secondary prevention for all children with echocardiographically detected subclinical valve disease is warranted has not been shown. (54) Valve surgery is the way to managed valve disease causing heart failure, unless the risk is deemed to high. The diffi culties associated with valve surgery in Africa are immediately apparent. The majority of the patients needing valve surgery are young and poor and availability of surgical resources and expertise is not widespread. (62) Tissue prosthesis are not durable in young patients (63) and mechanical prosthesis are complicated by inadequate anticoagulation due to diffi culties with follow up, thromboembolic events, hemorrhage, or infective endocarditis. (64) Mitral valve repair is preferable to mitral valve replacement and is feasible in a number of patients, but there is risk of needing reoperation, particularly if valve repair is performed in the presence of active rheumatic carditis. (65) Cardiopulmonary bypass during pregnancy is associated with high fetal loss. (66) Mitral valve replacement during pregnancy, if deemed the only option, should be delayed until after delivery whenever possible. (66, 67) Options for management of symptomatic mitral stenosis refractory to medical therapy and particularly complicating pregnancy include percutaneous balloon valvotomy or closed mitral commissurotomy. (67) (68) (69) Mitral balloon valvotomy is preferred for severe mitral stenosis with pliable leafl ets and without heavy commissural calcifi cation, (68) (71) but is an uncommon indication for mitral valve surgery in surgical series reported from Africa. (6) Valve diseases related to aging are the most common form of valve diseases in developed countries, (72) and are also encountered in the elderly in Africa. (73) However, age-related valve diseases of clinical signifi cance were not part of the spectrum of heart disease and risk factors in a recent cohort study of a large black urban population in Soweto, South Africa. (74) Congenital subvalvular aneurysms are rare and were also fi rst described in Africa. (75, 76) These aneurysm may be located below the mitral or aortic valve and be associated with regurgitation, systemic embolisation, or rupture and are thought to be related to congenital weakness between the muscular ventricular wall and fi brous skeleton of the valve annulus. (77) The cause of endomyocardial fi brosis is not well understood, but it is the most common cause of restrictive cardiomyopathy worldwide caused by deposition of fi brous tissue on endocardial surfaces causing heart failure associated with atrioventricular valve regurgitation. (78, 79) There is no medical therapy for this illness and surgical results of advanced disease are poor. 
